 | • レポートコード：GIR-107A12026 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、補助療法のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。補助療法の種類別市場規模（化学療法、放射線療法、ホルモン療法、その他）、用途別市場規模（病院、医療機関、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・補助療法の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck、Bayer、Johnson & Johnson、AstraZenca、Mylan、AbbVie、Novartis ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：化学療法、放射線療法、ホルモン療法、その他 ・用途別分析2016年-2026年：病院、医療機関、その他 ・補助療法の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・補助療法のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・補助療法のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・補助療法の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・補助療法の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Adjuvant Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Adjuvant Therapy size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Adjuvant Therapy market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Adjuvant Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chemotherapy
Radiotherapy
Hormonotherapy
Others
Market segment by Application, can be divided into
Hospital
Medical Institution
Others
Market segment by players, this report covers
Merck
Bayer
Johnson & Johnson
AstraZenca
Mylan
AbbVie
Novartis
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Adjuvant Therapy
1.2 Classification of Adjuvant Therapy by Type
1.2.1 Overview: Global Adjuvant Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Adjuvant Therapy Revenue Market Share by Type in 2020
1.2.3 Chemotherapy
1.2.4 Radiotherapy
1.2.5 Hormonotherapy
1.2.6 Others
1.3 Global Adjuvant Therapy Market by Application
1.3.1 Overview: Global Adjuvant Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Medical Institution
1.3.4 Others
1.4 Global Adjuvant Therapy Market Size & Forecast
1.5 Global Adjuvant Therapy Market Size and Forecast by Region
1.5.1 Global Adjuvant Therapy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Adjuvant Therapy Market Size by Region, (2016-2021)
1.5.3 North America Adjuvant Therapy Market Size and Prospect (2016-2026)
1.5.4 Europe Adjuvant Therapy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Adjuvant Therapy Market Size and Prospect (2016-2026)
1.5.6 South America Adjuvant Therapy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Adjuvant Therapy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Adjuvant Therapy Market Drivers
1.6.2 Adjuvant Therapy Market Restraints
1.6.3 Adjuvant Therapy Trends Analysis
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Adjuvant Therapy Product and Solutions
2.1.4 Merck Adjuvant Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Merck Recent Developments and Future Plans
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Adjuvant Therapy Product and Solutions
2.2.4 Bayer Adjuvant Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Bayer Recent Developments and Future Plans
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Adjuvant Therapy Product and Solutions
2.3.4 Johnson & Johnson Adjuvant Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Johnson & Johnson Recent Developments and Future Plans
2.4 AstraZenca
2.4.1 AstraZenca Details
2.4.2 AstraZenca Major Business
2.4.3 AstraZenca Adjuvant Therapy Product and Solutions
2.4.4 AstraZenca Adjuvant Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 AstraZenca Recent Developments and Future Plans
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan Adjuvant Therapy Product and Solutions
2.5.4 Mylan Adjuvant Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Mylan Recent Developments and Future Plans
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business
2.6.3 AbbVie Adjuvant Therapy Product and Solutions
2.6.4 AbbVie Adjuvant Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 AbbVie Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Adjuvant Therapy Product and Solutions
2.7.4 Novartis Adjuvant Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Novartis Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Adjuvant Therapy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Adjuvant Therapy Players Market Share
3.2.2 Top 10 Adjuvant Therapy Players Market Share
3.2.3 Market Competition Trend
3.3 Adjuvant Therapy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Adjuvant Therapy Revenue and Market Share by Type (2016-2021)
4.2 Global Adjuvant Therapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Adjuvant Therapy Revenue Market Share by Application (2016-2021)
5.2 Adjuvant Therapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Adjuvant Therapy Revenue by Type (2016-2026)
6.2 North America Adjuvant Therapy Revenue by Application (2016-2026)
6.3 North America Adjuvant Therapy Market Size by Country
6.3.1 North America Adjuvant Therapy Revenue by Country (2016-2026)
6.3.2 United States Adjuvant Therapy Market Size and Forecast (2016-2026)
6.3.3 Canada Adjuvant Therapy Market Size and Forecast (2016-2026)
6.3.4 Mexico Adjuvant Therapy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Adjuvant Therapy Revenue by Type (2016-2026)
7.2 Europe Adjuvant Therapy Revenue by Application (2016-2026)
7.3 Europe Adjuvant Therapy Market Size by Country
7.3.1 Europe Adjuvant Therapy Revenue by Country (2016-2026)
7.3.2 Germany Adjuvant Therapy Market Size and Forecast (2016-2026)
7.3.3 France Adjuvant Therapy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Adjuvant Therapy Market Size and Forecast (2016-2026)
7.3.5 Russia Adjuvant Therapy Market Size and Forecast (2016-2026)
7.3.6 Italy Adjuvant Therapy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Adjuvant Therapy Revenue by Type (2016-2026)
8.2 Asia-Pacific Adjuvant Therapy Revenue by Application (2016-2026)
8.3 Asia-Pacific Adjuvant Therapy Market Size by Region
8.3.1 Asia-Pacific Adjuvant Therapy Revenue by Region (2016-2026)
8.3.2 China Adjuvant Therapy Market Size and Forecast (2016-2026)
8.3.3 Japan Adjuvant Therapy Market Size and Forecast (2016-2026)
8.3.4 South Korea Adjuvant Therapy Market Size and Forecast (2016-2026)
8.3.5 India Adjuvant Therapy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Adjuvant Therapy Market Size and Forecast (2016-2026)
8.3.7 Australia Adjuvant Therapy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Adjuvant Therapy Revenue by Type (2016-2026)
9.2 South America Adjuvant Therapy Revenue by Application (2016-2026)
9.3 South America Adjuvant Therapy Market Size by Country
9.3.1 South America Adjuvant Therapy Revenue by Country (2016-2026)
9.3.2 Brazil Adjuvant Therapy Market Size and Forecast (2016-2026)
9.3.3 Argentina Adjuvant Therapy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Adjuvant Therapy Revenue by Type (2016-2026)
10.2 Middle East & Africa Adjuvant Therapy Revenue by Application (2016-2026)
10.3 Middle East & Africa Adjuvant Therapy Market Size by Country
10.3.1 Middle East & Africa Adjuvant Therapy Revenue by Country (2016-2026)
10.3.2 Turkey Adjuvant Therapy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Adjuvant Therapy Market Size and Forecast (2016-2026)
10.3.4 UAE Adjuvant Therapy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Adjuvant Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Adjuvant Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Adjuvant Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Adjuvant Therapy Revenue (USD Million) by Region (2016-2021)
Table 5. Global Adjuvant Therapy Revenue Market Share by Region (2021-2026)
Table 6. Merck Corporate Information, Head Office, and Major Competitors
Table 7. Merck Major Business
Table 8. Merck Adjuvant Therapy Product and Solutions
Table 9. Merck Adjuvant Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Bayer Corporate Information, Head Office, and Major Competitors
Table 11. Bayer Major Business
Table 12. Bayer Adjuvant Therapy Product and Solutions
Table 13. Bayer Adjuvant Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 15. Johnson & Johnson Major Business
Table 16. Johnson & Johnson Adjuvant Therapy Product and Solutions
Table 17. Johnson & Johnson Adjuvant Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. AstraZenca Corporate Information, Head Office, and Major Competitors
Table 19. AstraZenca Major Business
Table 20. AstraZenca Adjuvant Therapy Product and Solutions
Table 21. AstraZenca Adjuvant Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Mylan Corporate Information, Head Office, and Major Competitors
Table 23. Mylan Major Business
Table 24. Mylan Adjuvant Therapy Product and Solutions
Table 25. Mylan Adjuvant Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. AbbVie Corporate Information, Head Office, and Major Competitors
Table 27. AbbVie Major Business
Table 28. AbbVie Adjuvant Therapy Product and Solutions
Table 29. AbbVie Adjuvant Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Novartis Corporate Information, Head Office, and Major Competitors
Table 31. Novartis Major Business
Table 32. Novartis Adjuvant Therapy Product and Solutions
Table 33. Novartis Adjuvant Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Global Adjuvant Therapy Revenue (USD Million) by Players (2019-2021)
Table 35. Global Adjuvant Therapy Revenue Share by Players (2019-2021)
Table 36. Breakdown of Adjuvant Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Adjuvant Therapy Players Head Office, Products and Services Provided
Table 38. Adjuvant Therapy Mergers & Acquisitions in the Past Five Years
Table 39. Adjuvant Therapy New Entrants and Expansion Plans
Table 40. Global Adjuvant Therapy Revenue (USD Million) by Type (2016-2021)
Table 41. Global Adjuvant Therapy Revenue Share by Type (2016-2021)
Table 42. Global Adjuvant Therapy Revenue Forecast by Type (2021-2026)
Table 43. Global Adjuvant Therapy Revenue by Application (2016-2021)
Table 44. Global Adjuvant Therapy Revenue Forecast by Application (2021-2026)
Table 45. North America Adjuvant Therapy Revenue by Type (2016-2021) & (USD Million)
Table 46. North America Adjuvant Therapy Revenue by Type (2021-2026) & (USD Million)
Table 47. North America Adjuvant Therapy Revenue by Application (2016-2021) & (USD Million)
Table 48. North America Adjuvant Therapy Revenue by Application (2021-2026) & (USD Million)
Table 49. North America Adjuvant Therapy Revenue by Country (2016-2021) & (USD Million)
Table 50. North America Adjuvant Therapy Revenue by Country (2021-2026) & (USD Million)
Table 51. Europe Adjuvant Therapy Revenue by Type (2016-2021) & (USD Million)
Table 52. Europe Adjuvant Therapy Revenue by Type (2021-2026) & (USD Million)
Table 53. Europe Adjuvant Therapy Revenue by Application (2016-2021) & (USD Million)
Table 54. Europe Adjuvant Therapy Revenue by Application (2021-2026) & (USD Million)
Table 55. Europe Adjuvant Therapy Revenue by Country (2016-2021) & (USD Million)
Table 56. Europe Adjuvant Therapy Revenue by Country (2021-2026) & (USD Million)
Table 57. Asia-Pacific Adjuvant Therapy Revenue by Type (2016-2021) & (USD Million)
Table 58. Asia-Pacific Adjuvant Therapy Revenue by Type (2021-2026) & (USD Million)
Table 59. Asia-Pacific Adjuvant Therapy Revenue by Application (2016-2021) & (USD Million)
Table 60. Asia-Pacific Adjuvant Therapy Revenue by Application (2021-2026) & (USD Million)
Table 61. Asia-Pacific Adjuvant Therapy Revenue by Region (2016-2021) & (USD Million)
Table 62. Asia-Pacific Adjuvant Therapy Revenue by Region (2021-2026) & (USD Million)
Table 63. South America Adjuvant Therapy Revenue by Type (2016-2021) & (USD Million)
Table 64. South America Adjuvant Therapy Revenue by Type (2021-2026) & (USD Million)
Table 65. South America Adjuvant Therapy Revenue by Application (2016-2021) & (USD Million)
Table 66. South America Adjuvant Therapy Revenue by Application (2021-2026) & (USD Million)
Table 67. South America Adjuvant Therapy Revenue by Country (2016-2021) & (USD Million)
Table 68. South America Adjuvant Therapy Revenue by Country (2021-2026) & (USD Million)
Table 69. Middle East & Africa Adjuvant Therapy Revenue by Type (2016-2021) & (USD Million)
Table 70. Middle East & Africa Adjuvant Therapy Revenue by Type (2021-2026) & (USD Million)
Table 71. Middle East & Africa Adjuvant Therapy Revenue by Application (2016-2021) & (USD Million)
Table 72. Middle East & Africa Adjuvant Therapy Revenue by Application (2021-2026) & (USD Million)
Table 73. Middle East & Africa Adjuvant Therapy Revenue by Country (2016-2021) & (USD Million)
Table 74. Middle East & Africa Adjuvant Therapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Adjuvant Therapy Picture
Figure 2. Global Adjuvant Therapy Revenue Market Share by Type in 2020
Figure 3. Chemotherapy
Figure 4. Radiotherapy
Figure 5. Hormonotherapy
Figure 6. Others
Figure 7. Adjuvant Therapy Revenue Market Share by Application in 2020
Figure 8. Hospital Picture
Figure 9. Medical Institution Picture
Figure 10. Others Picture
Figure 11. Global Adjuvant Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Adjuvant Therapy Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Adjuvant Therapy Revenue Market Share by Region (2016-2026)
Figure 14. Global Adjuvant Therapy Revenue Market Share by Region in 2020
Figure 15. North America Adjuvant Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Adjuvant Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Adjuvant Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Adjuvant Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Adjuvant Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Adjuvant Therapy Market Drivers
Figure 21. Adjuvant Therapy Market Restraints
Figure 22. Adjuvant Therapy Market Trends
Figure 23. Merck Recent Developments and Future Plans
Figure 24. Bayer Recent Developments and Future Plans
Figure 25. Johnson & Johnson Recent Developments and Future Plans
Figure 26. AstraZenca Recent Developments and Future Plans
Figure 27. Mylan Recent Developments and Future Plans
Figure 28. AbbVie Recent Developments and Future Plans
Figure 29. Novartis Recent Developments and Future Plans
Figure 30. Global Adjuvant Therapy Revenue Share by Players in 2020
Figure 31. Adjuvant Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 32. Global Top 3 Players Adjuvant Therapy Revenue Market Share in 2020
Figure 33. Global Top 10 Players Adjuvant Therapy Revenue Market Share in 2020
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 35. Global Adjuvant Therapy Revenue Share by Type in 2020
Figure 36. Global Adjuvant Therapy Market Share Forecast by Type (2021-2026)
Figure 37. Global Adjuvant Therapy Revenue Share by Application in 2020
Figure 38. Global Adjuvant Therapy Market Share Forecast by Application (2021-2026)
Figure 39. North America Adjuvant Therapy Sales Market Share by Type (2016-2026)
Figure 40. North America Adjuvant Therapy Sales Market Share by Application (2016-2026)
Figure 41. North America Adjuvant Therapy Revenue Market Share by Country (2016-2026)
Figure 42. United States Adjuvant Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Adjuvant Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Adjuvant Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Adjuvant Therapy Sales Market Share by Type (2016-2026)
Figure 46. Europe Adjuvant Therapy Sales Market Share by Application (2016-2026)
Figure 47. Europe Adjuvant Therapy Revenue Market Share by Country (2016-2026)
Figure 48. Germany Adjuvant Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Adjuvant Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Adjuvant Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Adjuvant Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Adjuvant Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Adjuvant Therapy Sales Market Share by Type (2016-2026)
Figure 54. Asia-Pacific Adjuvant Therapy Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Adjuvant Therapy Revenue Market Share by Region (2016-2026)
Figure 56. China Adjuvant Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Adjuvant Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South Korea Adjuvant Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Adjuvant Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Adjuvant Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Adjuvant Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Adjuvant Therapy Sales Market Share by Type (2016-2026)
Figure 63. South America Adjuvant Therapy Sales Market Share by Application (2016-2026)
Figure 64. South America Adjuvant Therapy Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Adjuvant Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Adjuvant Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East and Africa Adjuvant Therapy Sales Market Share by Type (2016-2026)
Figure 68. Middle East and Africa Adjuvant Therapy Sales Market Share by Application (2016-2026)
Figure 69. Middle East and Africa Adjuvant Therapy Revenue Market Share by Country (2016-2026)
Figure 70. Turkey Adjuvant Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Saudi Arabia Adjuvant Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. UAE Adjuvant Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source
世界の陽子線治療市場 2021：企業別、地域別、種類・用途別 The Proton Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…- 世界の長寿・老化防止療法市場 2021：企業別、地域別、種類・用途別 The Longevity and Anti-senescence Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 世界のTILセラピー市場 2021：企業別、地域別、種類・用途別 The TIL Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent…
- 世界の中枢神経系疾患用遺伝子治療市場 2021：企業別、地域別、種類・用途別 The Gene Therapy for CNS Disorders market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界の筋骨格系障害幹細胞治療市場 2021：企業別、地域別、種類・用途別 The Musculoskeletal Disorder Stem Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…